跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lifetime Royal Jelly 2250mg Premium Gold Powder Capsule - TGA Drug Approval Details
Approvals
/
TGA
/
Lifetime Royal Jelly 2250mg Premium Gold Powder Capsule
Approved
STANDARD
Lifetime Royal Jelly 2250mg Premium Gold Powder Capsule
Lifetime Pharmaceuticals
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
35afd8309474f0d8
Company
Lifetime Pharmaceuticals
Type
Standard
Approval Details
Approval Id
35afd8309474f0d8
Product Name
Lifetime Royal Jelly 2250mg Premium Gold Powder Capsule
Artg Id
301007
Artg Name
Lifetime Royal Jelly 2250mg Premium Gold Powder Capsule
Sponsor
Lifetime Pharmaceuticals
Company Detail Path
/organization/proudex-pharmaceuticals-pty-ltd
Artg Date
2018-03-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
35afd8309474f0d8
Type
Standard
Back to TGA Approvals
